Component,Publication Grant Number,Publication Doi,Publication Journal,Pubmed Id,Pubmed Url,Publication Title,Publication Year,Publication Keywords,Publication Authors,Publication Abstract,Publication Assay,Publication Tumor Type,Publication Tissue,Publication Dataset Alias,Publication Accessibility,PublicationView_id,Id,entityId
PublicationView,CA264610,10.1200/jco.23.00880,J Clin Oncol,37729596,https://pubmed.ncbi.nlm.nih.gov/37729596,Prognostic and Pharmacotypic Heterogeneity of Hyperdiploidy in Childhood ALL,2023,,"Shawn H R Lee, Emily Ashcraft, Wenjian Yang, Kathryn G Roberts, Yoshihiro Gocho, Lauren Rowland, Hiroto Inaba, Seth E Karol, Sima Jeha, Kristine R Crews, Charles G Mullighan, Mary V Relling, William E Evans, Cheng Cheng, Jun J Yang, Ching-Hon Pui","Purpose: High hyperdiploidy, the largest and favorable subtype of childhood ALL, exhibits significant biological and prognostic heterogeneity. However, factors contributing to the varied treatment response and the optimal definition of hyperdiploidy remain uncertain. Methods: We analyzed outcomes of patients treated on two consecutive frontline ALL protocols, using six different definitions of hyp(Read more on Pubmed)",Pending Annotation,Pending Annotation,Pending Annotation,,Restricted Access,37729596,0e8c66aa-3157-4849-9c60-5217a5ba4604,syn52566258
